NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
25.06
-0.11 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
25.07
0.04%
After-hours: Aug 15, 2025, 04:10 PM EDT
-0.44% (1D)
| Bid | 24.23 |
| Market Cap | 2.82B |
| Revenue (ttm) | 64.01M |
| Net Income (ttm) | -165.72M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -15.76 |
| Forward PE | -14.01 |
| Analyst | Buy |
| Ask | 26.31 |
| Volume | 914,111 |
| Avg. Volume (20D) | 852,932 |
| Open | 25.24 |
| Previous Close | 25.17 |
| Day's Range | 24.88 - 25.64 |
| 52-Week Range | 14.06 - 27.29 |
| Beta | -0.01 |
About NAMS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAMS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAMS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
NewAmsterdam Pharma has released their quartely earnings
on Aug 6, 2025:
Next Earnings Release
NewAmsterdam Pharma N.V. is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
+5.07%
NAMS stock has given up its prior gain. NewAmsterd...
Unlock content with
Pro Subscription
4 weeks ago
+5.07%
NewAmsterdam Pharma shares are trading higher. Goldman Sachs initiated coverage on the stock with a price target of $27.
1 week ago · fool.com
NewAmsterdam (NAMS) Q2 Revenue Jumps 49%NewAmsterdam (NAMS) Q2 Revenue Jumps 49%
